Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Walshaw

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Annals of the Royal College of Surgeons of England|June 11, 2025
Water-soluble contrast agent use in adhesional small bowel obstruction: a survey of surgical practices and clinical trial considerationsK Aimar, J Walshaw, A Peckham-Cooper, et al.
Respiratory Medicine|July 1, 1994
Twenty-four-hour tracheal pH monitoring--a simple and non-hazardous investigationC I Jack, M J Walshaw, J Tran, et al.
Annals of the American Thoracic Society|July 20, 2019
Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens. A Cohort Study Using National Registry DataFreddy J Frost, Dilip S Nazareth, Susan C Charman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosisA Mirakhur, M J Gallagher, M J Ledson, et al.
Radiology|March 15, 2022
Use of Dynamic Chest Radiography to Assess Treatment of Pulmonary Exacerbations in Cystic FibrosisThomas Simon FitzMaurice, Caroline McCann, Dilip S Nazareth, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 7, 2013
Extensive diversification is a common feature of Pseudomonas aeruginosa populations during respiratory infections in cystic fibrosisAbdul Ashish, Steve Paterson, Eilidh Mowat, et al.
The European Respiratory Journal|October 8, 1998
Four years' experience of intravenous colomycin in an adult cystic fibrosis unitM J Ledson, M J Gallagher, C Cowperthwaite, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 1, 2022
Measuring the effect of elexacaftor/tezacaftor/ivacaftor combination therapy on the respiratory pump in people with CF using dynamic chest radiographyThomas S FitzMaurice, Caroline McCann, Dilip Nazareth, et al.
Thorax|August 30, 2008
Transmission of Pseudomonas aeruginosa epidemic strain from a patient with cystic fibrosis to a pet catK Mohan, J L Fothergill, J Storrar, et al.
Journal of Medical Microbiology|February 6, 2010
Empyema due to a highly transmissible Pseudomonas aeruginosa strain in an adult cystic fibrosis patientKamlesh Mohan, Vinay Lakshman, Joanne L Fothergill, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Annals of the Royal College of Surgeons of England|June 11, 2025
Water-soluble contrast agent use in adhesional small bowel obstruction: a survey of surgical practices and clinical trial considerationsK Aimar, J Walshaw, A Peckham-Cooper, et al.
Respiratory Medicine|July 1, 1994
Twenty-four-hour tracheal pH monitoring--a simple and non-hazardous investigationC I Jack, M J Walshaw, J Tran, et al.
Annals of the American Thoracic Society|July 20, 2019
Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens. A Cohort Study Using National Registry DataFreddy J Frost, Dilip S Nazareth, Susan C Charman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosisA Mirakhur, M J Gallagher, M J Ledson, et al.
Radiology|March 15, 2022
Use of Dynamic Chest Radiography to Assess Treatment of Pulmonary Exacerbations in Cystic FibrosisThomas Simon FitzMaurice, Caroline McCann, Dilip S Nazareth, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 7, 2013
Extensive diversification is a common feature of Pseudomonas aeruginosa populations during respiratory infections in cystic fibrosisAbdul Ashish, Steve Paterson, Eilidh Mowat, et al.
The European Respiratory Journal|October 8, 1998
Four years' experience of intravenous colomycin in an adult cystic fibrosis unitM J Ledson, M J Gallagher, C Cowperthwaite, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 1, 2022
Measuring the effect of elexacaftor/tezacaftor/ivacaftor combination therapy on the respiratory pump in people with CF using dynamic chest radiographyThomas S FitzMaurice, Caroline McCann, Dilip Nazareth, et al.
Thorax|August 30, 2008
Transmission of Pseudomonas aeruginosa epidemic strain from a patient with cystic fibrosis to a pet catK Mohan, J L Fothergill, J Storrar, et al.
Journal of Medical Microbiology|February 6, 2010
Empyema due to a highly transmissible Pseudomonas aeruginosa strain in an adult cystic fibrosis patientKamlesh Mohan, Vinay Lakshman, Joanne L Fothergill, et al.
Pageof 10